Milestones
2024
- CARDIOVASCULAR TECH FORUM powered by octane
September 12-13
2022
- Series B First Tranche financing
2021
- January 6 – First patient series published – demonstrating “best ever” left ventricular remodeling ever published. The Journal of Thoracic and Cardiovascular Surgery published – “First in human experience with an epicardial beating heart device for secondary mitral regurgitation,”
Thourani et al.
2020
- October 9 – Mitre Medical is accepted into the Proof of Concept program for the US-Japan Regulatory initiative known as Harmonization by Doing (HBD). HBD is focused on moving Japanese and U.S. clinical study sponsors and regulatory agencies toward the use of a single global clinical trial protocol for evaluating cardiovascular devices rather than parallel country-specific protocols.
2019
- December 13 – Dr. George Presents the Mini-T approach at the CSI Devices for Heart Failure Conference, Paris, France, during his talk “Epicardial treatment for FMR and heart failure”
- June 27 – MedTech Strategist article interview with Mitre Medical titled, Mitre Medical: A Dual Strategy for Mitral Valve Repair
- May 2-3 – Mitre Sponsors the AATS Mitral Conclave, NYC, NY. Friday Lunch & Learn Presentation by Dr. Isaac George, MD. The 2019 AATS Mitral Conclave continues its tradition as the benchmark meeting in the field of mitral valve disease. The faculty includes over 70 international leaders in the field, and the program features over 200 invited or submitted lectures, abstracts, and video presentations. Watch the video.
- April – Milestone Achievement: 1-Year Follow-Up for ENRAPT-MR Study. The initial patient series has reached the 1-Year Milestone for the ENRAPT-MR Study for the Treatment of Mitral Touch for Coronary Artery Bypass Patients with moderate to severe MR
- March 29-30 – Mitre is a proud Exhibitor at the Society of Thoracic Surgeons’ Workshop on Robotic Cardiac Surgery, at the Intuitive Surgical Training Facility in ATL, GA.
March – Addition of surgical experts Sam Balkhy, MD, Isaac George, MD and Gan Dunnington, MD to the Scientific Advisory Board
The STS Workshop on Robotic Cardiac Surgery will offer extensive hands-on procedural experience in a state-of-the-art robotics training facility. Specially designed for surgical teams—a surgeon and a bedside assistant or other surgical team member—the Workshop will put participants in a realistic, cardiac robotics simulation environment where they can hone their skills in mitral valve repair, coronary bypass, and other cardiac surgery procedures
2018
- Completion of the feasibility phase of the ENRAPT-MR Trial
- Formation of Scientific Advisory Board with Dr. Michael Mack and Dr. Vinod Thourani
- Formation of Strategic Advisory Board with distinguished cardiac surgery executive, Ms. Maria Sainz
- Presentation of ENRAPT-MR 6 Month Results at EACTS 2018, Milan, Italy
- FDA Pre-Submission Meeting
2017
- Received clearance for the Epicardial Mitral Repair Trial (ENRAPT-MR Trial)
- Successful enrollment of first patients treated with the Mitral Touch Implant in the ENRAPT-MR Trial
- Additional patents issued
2016
- Series A financing completed
2014
- Patent Issued by US PTO
2012
- Mitre Medical company formation
- Mitre Medical acquires patent license from Maquet Cardiovascular/Getinge Group